BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25952033)

  • 1. Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.
    Mol L; Koopman M; Ottevanger PB; Punt CJ
    J Natl Cancer Inst; 2015 Jun; 107(6):djv104. PubMed ID: 25952033
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
    Lamont EB; Schilsky RL; He Y; Muss H; Cohen HJ; Hurria A; Meilleur A; Kindler HL; Venook A; Lilenbaum R; Niell H; Goldberg RM; Joffe S;
    J Natl Cancer Inst; 2015 Jan; 107(1):336. PubMed ID: 25432408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes when cancer treatment is delivered on, or off, a clinical trial: implications for generalizability of study results.
    Markman M
    Oncology; 2011; 81(3-4):141-2. PubMed ID: 22024941
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 5. Research in pancreatic cancer: an update after ASCO 2012.
    Saif MW
    JOP; 2012 Jul; 13(4):330-1. PubMed ID: 22797382
    [No Abstract]   [Full Text] [Related]  

  • 6. Extra-appendiceal neuroendocrine neoplasms in children - data from the GPOH-MET 97 Study.
    Redlich A; Wechsung K; Boxberger N; Leuschner I; Vorwerk P
    Klin Padiatr; 2013 Nov; 225(6):315-9. PubMed ID: 24158887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
    Giuliani J; Bonetti A
    Recenti Prog Med; 2017 Mar; 108(3):152-154. PubMed ID: 28398410
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pancreatic carcinoma: therapeutic nihilism?
    Wils JA
    Recent Results Cancer Res; 1988; 110():87-94. PubMed ID: 3043600
    [No Abstract]   [Full Text] [Related]  

  • 9. Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.
    Luedke DW; Luedke SL; Martelo O; Quesenberry P; Birch R; Schlueter J; Hake J; Logan T
    Cancer Treat Rep; 1986 May; 70(5):651-3. PubMed ID: 3011259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
    Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
    Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion - clinical trials and combination therapies in lung cancer. Clinical trial design.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S176-8. PubMed ID: 18520307
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
    Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
    N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
    [No Abstract]   [Full Text] [Related]  

  • 13. Locally advanced non-metastatic pancreatic cancer--can we do more?
    Hawkins MA; Tait D
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):532-4. PubMed ID: 18614342
    [No Abstract]   [Full Text] [Related]  

  • 14. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J
    Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
    Levy A; Chargari C; Huguet F; VĂ©drine L; Deutsch E
    Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
    Krug S; Gress TM; Michl P; Rinke A
    Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
    Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for pancreatic cancer.
    Aung KL; Moore MJ
    Lancet Oncol; 2015 Jul; 16(7):748-9. PubMed ID: 26067686
    [No Abstract]   [Full Text] [Related]  

  • 19. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
    J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of somatostatin analogs in the management of carcinoid tumors.
    Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R
    J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.